Compare SNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNT | VNRX |
|---|---|---|
| Founded | 1965 | N/A |
| Country | Canada | United States |
| Employees | N/A | 75 |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.6M | 7.2M |
| IPO Year | 2023 | 2012 |
| Metric | SNT | VNRX |
|---|---|---|
| Price | $1.63 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 10.8K | ★ 1.8M |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $355.66 |
| Revenue Next Year | N/A | $849.08 |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.43 | $0.13 |
| 52 Week High | $5.34 | $3.26 |
| Indicator | SNT | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 29.22 |
| Support Level | $1.43 | $0.22 |
| Resistance Level | $1.89 | $0.27 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 66.67 | 24.28 |
Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.